Literature DB >> 20685879

An inositol 1,4,5-triphosphate (IP3)-IP3 receptor pathway is required for insulin-stimulated glucose transporter 4 translocation and glucose uptake in cardiomyocytes.

A E Contreras-Ferrat1, B Toro, R Bravo, V Parra, C Vásquez, C Ibarra, D Mears, M Chiong, E Jaimovich, A Klip, S Lavandero.   

Abstract

Intracellular calcium levels ([Ca2+]i) and glucose uptake are central to cardiomyocyte physiology, yet connections between them have not been studied. We investigated whether insulin regulates [Ca2+]i in cultured cardiomyocytes, the participating mechanisms, and their influence on glucose uptake via SLC2 family of facilitative glucose transporter 4 (GLUT4). Primary neonatal rat cardiomyocytes were preloaded with the Ca2+ fluorescent dye fluo3-acetoxymethyl ester compound (AM) and visualized by confocal microscopy. Ca2+ transport pathways were selectively targeted by chemical and molecular inhibition. Glucose uptake was assessed using [3H]2-deoxyglucose, and surface GLUT4 levels were quantified in nonpermeabilized cardiomyocytes transfected with GLUT4-myc-enhanced green fluorescent protein. Insulin elicited a fast, two-component, transient increase in [Ca2+]i. Nifedipine and ryanodine prevented only the first component. The second one was reduced by inositol-1,4,5-trisphosphate (IP3)-receptor-selective inhibitors (xestospongin C, 2 amino-ethoxydiphenylborate), by type 2 IP3 receptor knockdown via small interfering RNA or by transfected Gβγ peptidic inhibitor βARKct. Insulin-stimulated glucose uptake was prevented by bis(2-aminophenoxy)ethane-N,N,N',N'-tetra-acetic acid-AM, 2-amino-ethoxydiphenylborate, and βARK-ct but not by nifedipine or ryanodine. Similarly, insulin-dependent exofacial exposure of GLUT4-myc-enhanced green fluorescent protein was inhibited by bis(2-aminophenoxy)ethane-N,N,N',N'-tetra-acetic acid-AM and xestospongin C but not by nifedipine. Phosphatidylinositol 3-kinase and Akt were also required for the second phase of Ca2+ release and GLUT4 translocation. Transfected dominant-negative phosphatidylinositol 3-kinase γ inhibited the latter. In conclusion, in primary neonatal cardiomyocytes, insulin induces an important component of Ca2+ release via IP3 receptor. This component signals to glucose uptake via GLUT4, revealing a so-far unrealized contribution of IP3-sensitive Ca2+ stores to insulin action. This pathway may influence cardiac metabolism in conditions yet to be explored in adult myocardium.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20685879     DOI: 10.1210/en.2010-0116

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  17 in total

Review 1.  Glucose Transporters in Cardiac Metabolism and Hypertrophy.

Authors:  Dan Shao; Rong Tian
Journal:  Compr Physiol       Date:  2015-12-15       Impact factor: 9.090

Review 2.  Signaling, cytoskeletal and membrane mechanisms regulating GLUT4 exocytosis.

Authors:  Nolan J Hoffman; Jeffrey S Elmendorf
Journal:  Trends Endocrinol Metab       Date:  2011-01-07       Impact factor: 12.015

3.  Chronic heart failure selectively induces regional heterogeneity of insulin-responsive glucose transporters.

Authors:  Bruce Ware; Marie Bevier; Yoshinori Nishijima; Suzanne Rogers; Cynthia A Carnes; Véronique A Lacombe
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-08-17       Impact factor: 3.619

Review 4.  Insulin and β Adrenergic Receptor Signaling: Crosstalk in Heart.

Authors:  Qin Fu; Qingtong Wang; Yang K Xiang
Journal:  Trends Endocrinol Metab       Date:  2017-02-28       Impact factor: 12.015

5.  Metabolic alterations derived from absence of Two-Pore Channel 1 at cardiac level.

Authors:  Vanessa Garcia-Rua; Sandra Feijoo-Bandin; Maria Garcia-Vence; Alana Aragon-Herrera; Susana B Bravo; Diego Rodriguez-Penas; Ana Mosquera-Leal; Pamela V Lear; John Parrington; Jana Alonso; Esther Rosello-Lleti; Manuel Portoles; Miguel Rivera; Jose Ramon Gonzalez-Juanatey; Francisca Lago
Journal:  J Biosci       Date:  2016-12       Impact factor: 1.826

Review 6.  An integrated mechanism of cardiomyocyte nuclear Ca(2+) signaling.

Authors:  Cristián Ibarra; Jose Miguel Vicencio; Manuel Varas-Godoy; Enrique Jaimovich; Beverly A Rothermel; Per Uhlén; Joseph A Hill; Sergio Lavandero
Journal:  J Mol Cell Cardiol       Date:  2014-07-02       Impact factor: 5.000

7.  Cardiac PI3K-Akt impairs insulin-stimulated glucose uptake independent of mTORC1 and GLUT4 translocation.

Authors:  Yi Zhu; Renata O Pereira; Brian T O'Neill; Christian Riehle; Olesya Ilkun; Adam R Wende; Tenley A Rawlings; Yi Cheng Zhang; Quanjiang Zhang; Amira Klip; Ichiro Shiojima; Kenneth Walsh; E Dale Abel
Journal:  Mol Endocrinol       Date:  2012-11-30

8.  Angiotensin-(1-9) prevents cardiomyocyte hypertrophy by controlling mitochondrial dynamics via miR-129-3p/PKIA pathway.

Authors:  Cristian Sotomayor-Flores; Pablo Rivera-Mejías; César Vásquez-Trincado; Camila López-Crisosto; Pablo E Morales; Christian Pennanen; Iva Polakovicova; Víctor Aliaga-Tobar; Lorena García; Juan Carlos Roa; Beverly A Rothermel; Vinicius Maracaja-Coutinho; Hung Ho-Xuan; Gunter Meister; Mario Chiong; María Paz Ocaranza; Alejandro H Corvalán; Valentina Parra; Sergio Lavandero
Journal:  Cell Death Differ       Date:  2020-03-09       Impact factor: 15.828

9.  Electrical stimuli release ATP to increase GLUT4 translocation and glucose uptake via PI3Kγ-Akt-AS160 in skeletal muscle cells.

Authors:  Cesar Osorio-Fuentealba; Ariel E Contreras-Ferrat; Francisco Altamirano; Alejandra Espinosa; Qing Li; Wenyan Niu; Sergio Lavandero; Amira Klip; Enrique Jaimovich
Journal:  Diabetes       Date:  2012-12-28       Impact factor: 9.461

10.  Alteration in mitochondrial Ca(2+) uptake disrupts insulin signaling in hypertrophic cardiomyocytes.

Authors:  Tomás Gutiérrez; Valentina Parra; Rodrigo Troncoso; Christian Pennanen; Ariel Contreras-Ferrat; César Vasquez-Trincado; Pablo E Morales; Camila Lopez-Crisosto; Cristian Sotomayor-Flores; Mario Chiong; Beverly A Rothermel; Sergio Lavandero
Journal:  Cell Commun Signal       Date:  2014-11-07       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.